These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35770457)

  • 1. Paternal use of medications for inflammatory bowel disease and the risk of hospital-diagnosed infections in the offspring: a nationwide cohort study.
    Friedman S; Garvik OS; Nielsen J; Nørgård BM
    Aliment Pharmacol Ther; 2022 Sep; 56(5):823-830. PubMed ID: 35770457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
    Larsen MD; Friedman S; Magnussen B; Nørgård BM
    Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor.
    Meyer A; Taine M; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1269-1281.e9. PubMed ID: 34298191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
    Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
    Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Birth and Child Outcomes in Children Fathered by Men Treated with Antidiabetics Prior to Conception: A Nationwide Cohort Study.
    Nørgård BM; Fedder J; Jølving LR; Damkier P; Nielsen J
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
    Nørgård BM; Magnussen B; Larsen MD; Friedman S
    Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
    Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
    JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
    Biron A; Beaugerie L; Chazouillères O; Kirchgesner J
    Aliment Pharmacol Ther; 2022 Sep; 56(5):857-868. PubMed ID: 35789494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
    Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
    BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
    Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
    Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark.
    Nørgård BM; Nielsen J; Friedman S
    Aliment Pharmacol Ther; 2020 Sep; 52(5):829-842. PubMed ID: 32677731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases.
    Dheyriat L; Ward D; Beaugerie L; Jess T; Kirchgesner J
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):164-172.e11. PubMed ID: 35842123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
    Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study.
    Nørgård BM; Zegers FD; Knudsen T; Kjeldsen J; Lund K; Brodersen JB; Nielsen J
    Aliment Pharmacol Ther; 2023 Jul; 58(1):48-59. PubMed ID: 37078376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
    Bröms G; Granath F; Stephansson O; Kieler H
    Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
    Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
    Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
    Meyer A; Neumann A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Ann Intern Med; 2022 Oct; 175(10):1374-1382. PubMed ID: 36162111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
    Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
    Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.